中财网 中财网股票行情
拓新药业(301089)财务分析指标    年份：
截止日期2024-03-312023-12-312023-09-302023-06-302023-03-31
营业总收入(万元)10832.2583551.0074612.7965697.6255100.72
营业收入(万元)10832.2583551.0074612.7965697.6255100.72
营业总成本(万元)11160.4751716.2336644.7826777.4515386.86
营业成本(万元)7998.6635195.2522573.6916144.789512.77
净利润(万元)206.8424094.6431319.0830953.2930430.62
归属于母公司的净利润(万元)206.8424307.2731319.0830953.2930430.62
营业利润(万元)247.6932168.3938189.6139761.9940119.16
利润总额(万元)245.2231653.3437961.5139558.4339950.48
少数股东损益(万元)----------
基本每股收益(元)0.02(元)1.93(元)2.49(元)2.46(元)2.42(元)
稀释每股收益(元)0.02(元)1.93(元)2.49(元)2.46(元)2.42(元)
非经常性损益(万元)------537.17177.47
扣除非经常性损益后净利润(万元)-64.1423197.0230427.8130416.1330253.16
总资产(万元)181886.85183899.46186173.13188960.80203328.97
总负债(万元)21352.8223572.2718988.9223231.7634050.94
归属于母公司股东权益合计(万元)160534.03160327.19167184.21165729.04169278.02
股东权益合计(万元)160534.03160327.19167184.21165729.04169278.02
实收资本(股本)(万元)12654.4512654.4512600.0012600.0012600.00
资本公积(万元)62111.0062111.0061798.0360708.6459740.30
未分配利润(万元)79102.2578895.4186835.8386470.0490987.37
经营活动产生的现金流量净额(万元)5214.552695.345259.164971.5410606.02
经营活动现金流入小计(万元)13705.6469039.9461337.1750281.4840224.33
经营活动现金流出小计(万元)8491.0966344.6156078.0145309.9329618.31
投资活动产生的现金流量净额(万元)10603.27-12860.762553.30-17406.92-7646.72
投资活动现金流入小计(万元)19146.17129661.25124133.1880355.5851142.01
投资活动现金流出小计(万元)8542.90142522.02121579.8897762.5058788.73
筹资活动产生的现金流量净额(万元)---6907.23-9069.65-9069.65-3021.58
筹资活动现金流入小计(万元)--2160.03------
筹资活动现金流出小计(万元)--9067.269069.659069.653021.58
期末现金及现金等价物余额(万元)28916.8313073.3328877.828629.9930042.00
最后修改日期2024-04-222024-04-222023-10-242023-08-272023-04-26
↑返回页顶↑

转至拓新药业（301089）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。